See the DrugPatentWatch profile for cosentyx

Based on the information available, there is no indication of an "ideal time" to inject Cosentyx (secukinumab) daily. The medication's administration is typically based on the patient's and healthcare provider's convenience, rather than on a specific time of day.

Cosentyx is a prescription medication used to treat several conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It is administered via subcutaneous injection, and the frequency of administration depends on the specific condition being treated. For instance, plaque psoriasis may require injections once a week for the first 5 weeks, followed by once every 4 weeks thereafter [1].

It is crucial to follow the healthcare provider's instructions regarding the frequency and administration technique of Cosentyx. The manufacturer's instructions also provide detailed guidance on how to store and handle the medication [2].

In summary, there is no scientific evidence or consensus on an ideal time to inject Cosentyx daily. The timing of injections should be based on the patient's and healthcare provider's convenience, while adhering to the recommended administration frequency.

Sources:
[1] Cosentyx (secukinumab) [Prescribing Information]. Novartis Pharmaceuticals Corporation; 2021. Available from: <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>.
[2] Cosentyx (secukinumab) [Patient Information]. Novartis Pharmaceuticals Corporation; 2021. Available from: <https://www.novartis.us/sites/www.novartis.us/files/cosentyx-pi.pdf>.
[3] Cosentyx (secukinumab) [DrugPatentWatch]. DrugPatentWatch. Available from: <https://www.drugpatentwatch.com/drugs/cosentyx>.